Internal medicine (Tokyo, Japan)
Salvage Surgery for Lesions Resistant to Immune Checkpoint Inhibitors in a Case Suggestive of Pulmonary Pleomorphic Carcinoma.
Yoshio Nakano, Hiroka Serizawa, Yuri Enomoto, Yusuke Kuze, Norio Okamoto, Iwao Gohma, Yumiko Yasuhara
Published: 202510.2169/internalmedicine.5980-25
Abstract
Pulmonary pleomorphic carcinoma, a rare chemoresistant sarcomatoid lung cancer, responds to immune checkpoint inhibitors (ICIs). ICIs are effective when programmed death-ligand 1 (PD-L1) expression is high. We treated a 61-year-old man with pembroliz…
Preview only. Read the full abstract at the source